Chemical Structure : Simmiparib
CAS No.: 1551355-46-4
Catalog No.: PC-61950Not For Human Use, Lab Use Only.
Simmiparib is a novel potent, orally active PARP1/2 inhibitor with IC50 of 1.75/0.22 nM, inhibits PARP1 >90-fold more potently than the other PARPs (PARP3, TNKS1, TNKS2).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $298 | In stock | |
10 mg | $488 | In stock | |
25 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Simmiparib is a novel potent, orally active PARP1/2 inhibitor with IC50 of 1.75/0.22 nM, inhibits PARP1 >90-fold more potently than the other PARPs (PARP3, TNKS1, TNKS2).
Simmiparib selectively induces the accumulation of DNA double-strand breaks, G2/M arrest and apoptosis in homologous recombination repair (HR)-deficient cells.
Simmiparib potentiates the proliferative inhibition of several conventional anticancer drugs, reduces the poly(ADP-ribose) formation in HR-deficient cancer cells and xenografts.
Simmiparib exhibits 10-fold greater growth inhibition than olaparib against HR-deficient human cancer cell- or tissue-derived xenografts in nude mice.
M.Wt | 486.431 | |
Formula | C23H18F4N6O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-(4-fluoro-3-(5-methyl-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-7-carbonyl)benzyl)phthalazin-1(2H)-one |
1. Yuan B, et al. Cancer Lett. 2017 Feb 1;386:47-56.
2. Yang ZM, et al. Acta Pharmacol Sin. 2017 Jul;38(7):1038-1047.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright